Christian Celia, Catanzaro
09.07.1979, is Associate Professor in
Pharmaceutical Technology, Advanced Drug Delivery and Nanomedicine at the
University of Chieti – Pescara “. Christian Celia got his Pharm D with
residence in Hospital Pharmacy in 2008 at the University of Catanzaro and the
PhD in Pharmaceutical Science in 2012 in the same Institution. He spent 2 years
as Visiting Research at Houston Methodist Research Institute, Houston, Texas,
USA in the Department of Nanomedicine where he got the position of
Affiliated Scientist in 2012. In 2012,
he joined as Assistant Professor at the Department of Pharmacy of the University
of Chieti–Pescara “G. d’Annunzio” where he was promoted to Associate Professor
in 2017.
Current
Research
The main research fields are focused on
the synthesis, characterization, and applications in vitro and in vivo of
lipid, polymeric and hybrid nanocarriers for anti-cancer and anti-inflammatory
therapies. Recently started new thematic research focused on regenerative
medicine. Technical skills and expertise are main focused on colloidal and
applied chemistry design and characterization of nanocarriers.
Research
Outputs
Prof. Christian Celia published 105
research papers, 118 conference communications, 4 book chapters and 2 editorials.
He is co-author of 4 Italian patents (ITUB20154631A1 2017-04-12;
IT201900024622A·2019-12-18; IT202000004846A1·2021-09-06; IT102020000013042A1
2022-07-14) and 2 Patent Cooperation Treaty Applications
(WO2021124266A1·2021-06-24 and WO2021245547A1·2021-12-09).
Scopus Author ID: 15759016300;
ORCID:
https://orcid.org/0000-0002-0590-5429;
H-index: 44;
I10-indexd: 90
Documents: 105;
Total number of Citation: 5522
Collaborations
Prof. Christian Celia has national and
international collaborations (such as: Houston Methodist Research Institute,
University of Helsinki, University of Groningen, University of Tartu,
University of Porto, Italian Institute of Technology (IIT), Italian National
Center of Research (CNR), University of Catanzaro “Magna Graecia” (UMG), Mayo
Clinic University, i3S - Instituto de Investigação e Inovação em Saúde &
INEB-Instituto de Engenharia Biomédica, University of Bucharest “Carol Davila”)
which generated publications and projects awarded.
Research
Grants
Prof. Christian Celia is currently
involved in the following grants:
1) Role of miR-181a and miR-181b in B cell malignancies and
development of rational approaches for their use as therapeutic agents
(GR-2016-02363070); Progetto Finalizzato, Ministero della Salute; co-PI, PI
Research Unit 2; 443,200 €;
2) Tendon regeneration via targeted delivery of immune
modulators through liposomal nanoparticles (C41F17000220006); Italian Ministry
for University and Research (MUR), PON 2014-2020; PI; 120,000 €;
3) Lactobacillus reuteri DSM 17938 Membrane Vesicles (MVs):
In-Depth Characterization and Possible Applications for Human Health; BioGaia
A; co-PI; 60,000 €;
4) Perspectives For Future Innovation in Tendon Repair (P4FIT)
(955685); EU H2020-MCSA-ITN-EJD-2020; co-I, PI (Prof. Helder A. Santos,
University of Helsinki); 4,043,040 €;
5) Intelligenza artificiale e nanomedicine teranostiche
funzionalizzate con peptidi targhettanti per il trattamento selettivo del
glioblastoma. Dottorato di ricerca "innovativo a caratterizzazione industriale",
tematica Innovation, per l’Anno Accademico 2021/2022- Ciclo XXXVII,Italian
Minister of Innovation, University and Research (MIUR), University of L’Aquila.
Funds: 60,000 € (January 2022 - January 2025);
6) Strengthening of research structures and creation of R&D
"innovation ecosystems", set up of "territorial leaders in
R&D" National Recovery and Resilience Plan (NRRP), Mission 4,
Component 2 Investment 1.5, funded from the European Union –
NextGenerationEU–VITALITY. Total budget of the project: € 115.996.558,73;
Budget University of Chieti–Pescara “G.d’Annunzio” PI: Prof. Piero Di Carlo;
WP4 – Precision Medicine for cell/tissue therapy and pollution contrast –
Budget WP4: € 2.248.921,44, Co-leader of WP4.